Clinical trial
Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and…
NCT00255567 · Drugs for Neglected Diseases, Other · Completed
Key facts
| NCT number | NCT00255567 |
|---|---|
| Title | Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis |
| Official title | A Multicentre Comparative Trial of Efficacy and Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) Versus Combination of SSG and PM as the First Line Treatment for Visceral Leishmaniasis in Ethiopia, Kenya and Sudan |
| Lead sponsor | Drugs for Neglected Diseases, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Visceral Leishmaniasis |
| Intervention type | Drug |
| Interventions | Sodium Stibogluconate, Paromomycin sulphate, SSG and Paromomycin sulphate |
| Enrollment | 1,142 |
| Start date | Nov 1, 2004 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Nov 21, 2005 |
| Last update posted | Mar 22, 2016 |
| Countries | Ethiopia, Kenya, Sudan, Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: